The Evolving Context of Driver Mutations: ROS1 Rearrangement in Metastatic Non-Small Cell Lung Cancer

被引：0

作者：

DeCaire, Ximena ^{[1
]}

Streu, Erin ^{[1
]}

机构：

[1] CancerCare Manitoba, Winnipeg, MB, Canada

来源：

ONCOLOGY NURSING FORUM | 2016年 / 43卷 / 05期

关键词：

ambulatory care/office nursing; biotherapy/targeted therapies; clinical practice; lung cancer; CRIZOTINIB; ADENOCARCINOMA; FUSIONS;

D O I：

10.1188/16.ONF.544-547

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The discovery of driver mutations in non-small cell lung cancer (NSCLC) has led to the advent of targeted therapy and changed the clinical landscape. ROS1 is a rare driver mutation found in 1%-2% of patients diagnosed with NSCLC. This case highlights a young woman of Asian descent with no history of smoking diagnosed with NSCLC and ROS1 rearrangement and discusses the implications for oncology nurses in clinical practice.

引用

页码：544 / 547

页数：4

共 50 条

[41] CLINICAL ACTIVITY OF CRIZOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) HARBORING ROS1 GENE REARRANGEMENT
Ou, S. I.
Camidge, D. R.
Engelman, J.
Clark, J.
Tye, L.
Wilner, K.
Stephenson, P.
Varella-Garcia, M.
Iafrate, A.
Shaw, A. T.
ANNALS OF ONCOLOGY, 2012, 23 : 389 - 389
[42] ROS1 FUSION GENES: POTENTIAL DRUG TARGETS IN NON-SMALL CELL LUNG CANCER
Davies, Kurtis D.
Le, Anh T.
Theodoro, Mariana F.
Skokan, Margaret C.
Aisner, Dara L.
Terracciano, Luigi M.
Incarbone, Matteo
Roncalli, Massimo
Cappuzzo, Federico
Camidge, Ross D.
Doebele, Robert C.
Garcia, Marileila V.
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S146 - S146
[43] Comprehensive Profiling of ROS1 Fusions in Chinese Non-Small Cell Lung Cancer Patients
Xu, H.
Fan, X.
Tian, K.
Liang, X.
Li, J.
Cheng, Y.
Zhang, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S686 - S686
[44] Entrectinib in Patients with Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
Ahn, M.
Cho, B. C.
Siena, S.
Drilon, A.
De Braud, F.
Krebs, M.
John, T.
Karapetis, C.
Johnson, A.
Chow-Maneval, E.
Multani, P.
Doebele, R.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1783 - S1783
[45] ROS1 gene rearrangement and copy number gain in non-small cell lung cancer (vol 466, pg 45, 2015)
Jin, Yan
Sun, Ping-Li
Kim, Hyojin
Park, Eunhyang
Shim, Hyo Sup
Jheon, Sanghoon
Kim, Kwhanmien
Lee, Choon-Taek
Chung, Jin-Haeng
VIRCHOWS ARCHIV, 2015, 467 (01) : 123 - 123
[46] Immunotherapy in non-small cell lung cancer harbouring driver mutations
Addeo, Alfredo
Passaro, Antonio
Malapelle, Umberto
Banna, Giuseppe Luigi
Subbiah, Vivek
Friedlaender, Alex
CANCER TREATMENT REVIEWS, 2021, 96
[47] Concomitant Driver Gene Mutations in Non-Small Cell Lung Cancer
Wang, J.
Song, H.
Zhao, Z.
Zhang, Y.
Cui, L.
Bai, Y.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S423 - S424
[48] Non-small cell lung cancer with double driver mutations.
Osoegawa, Atsushi
Toyokawa, Gouji
Ohba, Taro
Miyawaki, Michiyo
Yamaguchi, Masafumi
Taguchi, Kenichi
Seto, Takashi
Takenoyama, Mitsuhiro
Ichinose, Yukito
Sugio, Kenji
CLINICAL CANCER RESEARCH, 2014, 20
[49] Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations
Solomon, B. J.
Martini, J-F.
Ou, S-H. I.
Chiari, R.
Soo, R. A.
Bearz, A.
Li, S.
Thurm, H.
Lin, C-C.
Riely, G. J.
Bauer, T. M.
Shaw, A. T.
ANNALS OF ONCOLOGY, 2018, 29 : 495 - 495
[50] Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer
Provencio, M.
Parente, D. Perez
Hasan, H.
Balea, B. Campos
Abreu, D. Rodriguez
Piqueras, M. Lopez Brea
Olson, S.
Pal, N.
Wilkinson, S.
de Oro-Pulido, F.
Gracia, P. Ruiz
Dols, M. Cobo
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S370 - S371

← 1 2 3 4 5 →